相关实验视频
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
概括
研究人员确定了CHS1基因,该基因对于在Saccharomyces cerevisiae中产生胆合成酶至关重要. 这种酶对细胞壁的完整性至关重要,它的基因被克隆和表征.
科学领域:
- 分子生物学分子生物学
- 酵母遗传学 酵母遗传学
背景情况:
- 氨酸合成酶是Saccharomyces cerevisiae中的一个与血膜结合的酶原体.
- 活性化合成酶合成不溶性,类似于芽痕中发现的素.
研究的目的:
- 为了克隆和表征编码奇合成酶的CHS1基因.
- 用裂变酵母证实CHS1是酸合成酶的结构基因.
主要方法:
- 隔离了基合成酶缺乏突变的突变物 (chs1).
- 对CHS1基因进行克隆.
- 在S. pombe.中表达CHS1-lacZ融合蛋白的表达.
- CHSI的基因破坏实验.
主要成果:
- CHS1基因具有3400个的开放读取框架,编码130kd的蛋白质.
- 在S. pombe中表达CHS1-lacZ赋予了基合成酶活性,证实了CHS1的作用.
- CHSI基因的破坏导致了体外丁合成酶活性的丧失,但维持了活力和体内丁水平的正常水平.
结论:
- CHS1是S. cerevisiae中基因合成酶的结构基因.
- 干扰CHS1会影响酸合成酶的活性,但不会影响细胞活力或基本功能.
相关概念视频
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K